Walmart to deliver US prescription medications in as soon as 30 minutes
Adds new details from Walmart spokesperson in paragraphs 6- 10
Oct 22 (Reuters) - U.S. retailer Walmart WMT.N on Tuesday said it will start delivering prescription medicines and medication refills along with groceries and other items as a single order within 30 minutes, upping the ante in its delivery competition against Amazon Inc AMZN.O.
Walmart's move comes a couple of weeks after Amazon announced plans to open pharmacies offering same-day delivery options across 20 new U.S. cities in 2025. It is also an extension of Walmart's previous efforts to mail prescription medications which typically took at least five to seven business days.
The speedier prescription delivery service would compete against other same-day pharmacy delivery offerings provided by retailers such as CVS Health CVS.N and Walgreens WBA.O.
Walmart, which operates 4,600 U.S. pharmacies and 3,000 vision centers across the country, said its pharmacy delivery service would be free for members of its $98 per year Walmart Plus membership program while non-members need to pay $9.95.
The service will be available to customers in 49 states by the end of January next year. Currently, customers in six states, namely Arkansas, Missouri, New York, Nevada, South Carolina and Wisconsin can usethe service.
Walmart said it decided to launch the service after more than half of respondents in an internal consumer research survey expressed a desire to have prescription medications delivered along with groceries and other items in one order.
Walmart will use drivers from its Spark Driver gig-delivery network to make some of these speedy deliveries, a company spokesman said in an email. The company also employs other options to deliver orders within 30 minutes, such as drones.
Barring controlled substances, refrigeration items and Medicare Part B products, such as wheelchairs and oxygen containers, all medications are delivery eligible.
When customers place a pharmacy delivery order through Walmart's app or website, they must agree to terms allowing Walmart's pharmacy staff to contact their physicians and provide counseling by phone, the spokesperson said.
A delivery timeframe does not begin until prescriptions are authorized by a customer's physician. Once approved, customers can add the medications to their cart and pick either same-day, on-demand or express delivery timeframe, the spokesperson added.
This prescription delivery service is Walmart's latest effort to focus on its pharmacy network, following its decision toclose51 health clinics and its virtual healthcare operations in April.
Reporting by Siddharth Cavale in New York and Ananya Mariam Rajesh in Bengaluru; Editing by Shreya Biswas and Alistair Bell
Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
